New COVID Variants in 2026 (NB.1.8.1, PQ.16.1.1, RF.5): Symptoms, Spread, and How to Protect Yourself

New COVID Variants in 2026 (NB.1.8.1, PQ.16.1.1, RF.5): Symptoms, Spread, and How to Protect Yourself

Medically reviewed by Dr. Ata Ullah, MD (Medicine)

Introduction

The coronavirus that causes COVID-19 has not disappeared; it has changed. In 2026, three Omicron descendants dominate the conversation: NB.1.8.1, nicknamed “Nimbus”; PQ.16.1.1, the newest variant on the World Health Organization’s monitoring list; and RF.5, first detected in Singapore and now found as far afield as England and India. Together they explain why Thailand is reporting roughly 15,000 new infections a week, and why travelers and health systems across China, India, Singapore, and Southeast Asia are paying attention again.

This guide covers all three in full: how they arose, what their mutations do inside the body, how to recognize the illness — including NB.1.8.1’s signature severe “razor-blade” sore throat — which tests confirm infection, current treatment recommendations, and concrete prevention and nutrition steps.

Every classification and statistic here is verified against current sources, including the World Health Organization’s variant tracker. The core message is reassuring: COVID-19 in 2026 remains mostly mild for most people, updated vaccines continue to protect against severe disease, and simple protective steps still work. But the virus rewards the prepared — so let us begin with why it keeps changing.

What Causes New COVID Variants?

Every new COVID variant is born from mutation. SARS-CoV-2 copies its RNA genome inside each infected person, and every replication carries a small chance of a copying error. Occasionally one gives the virus an advantage — tighter binding to human cells, easier spread, or better escape from antibodies built by earlier infection or vaccination — and that advantaged virus outcompetes its siblings to become a new lineage and eventually a named variant.

The mutations that matter most are in the spike protein, the surface structure that attaches to the ACE2 receptor on human airway cells. NB.1.8.1 carries several spike changes — T22N, F59S, G184S, A435S, F456L, T478I, Q493E — that sharpen attachment and blunt some neutralizing antibodies. Its descendant PQ.16.1.1 adds four more (S:D253G, S:N417T, S:D420N, S:I478T), which is why the WHO placed it under monitoring on 27 July 2026. RF.5 is defined by the single spike mutation S:K478T and evolved along the path JN.1 → LF.7 → PY.1 → RF.5; first found in Singapore in September 2025, it grew to roughly a quarter to a third of sequenced samples there by January 2026.

Omicron keeps spawning sub-lineages because its spike is already well-tuned to human airways and partially resistant to prior immunity, so new winners tend to be its children rather than unrelated strains. High community transmission accelerates the process, and dense cities plus travel carry successful mutations across borders — which is how NB.1.8.1 spread rapidly across China and Asia to dominate in Thailand.

Most at risk: adults over 60, the immunocompromised, the unvaccinated, and people with diabetes, heart, kidney, respiratory disease, or cancer — in Thailand’s recent data, nearly all weekly deaths fell into this group.

How the Disease Develops in the Body

SARS-CoV-2 spreads through the air: an infected person releases droplets and aerosol particles when breathing, talking, coughing, or sneezing, which others inhale or pick up from surfaces via hand-to-face contact. Indoor, crowded, poorly ventilated spaces are the highest-risk settings, which is why the 2026 variants spread so efficiently through Asia’s dense cities.

Inside the airway, the spike protein locks onto ACE2 receptors on nasal and throat-lining cells. Here the 2026 mutations earn their keep: lab testing found NB.1.8.1 binds ACE2 more strongly than several other variants examined, and neutralizing antibodies were about 1.5 times less effective against it than against the related lineage LP.8.1.1. Stronger binding means the virus enters cells with a smaller dose; weaker neutralization lets it infect people who already carry some immunity — the textbook definition of immune escape.

The timeline is predictable: two to four days of silent incubation, symptoms beginning on day two or three — often with the signature sore throat — peak viral load and contagiousness around days two to five, then the immune counterattack: fever, congestion, and fatigue as the body diverts energy to the fight. Most people turn the corner by days seven to ten.

Severity stays mostly mild in 2026 because of population immunity. After years of infections and vaccinations, almost everyone carries immunological memory — B cells and T cells that may not block infection but sharply reduce the chance of the virus reaching the lungs and causing pneumonia. For most healthy people, COVID-19 today behaves like a heavy cold.

How to Protect Yourself: Prevention

Stay current with vaccination. The updated COVID-19 vaccines remain effective at preventing severe disease, hospitalization, and death even against new variants, and the WHO assesses the additional global public-health risk from NB.1.8.1 as low. Priority goes to adults over 60, pregnant women, people with chronic illnesses, and healthcare workers. Guidance on when to get vaccinated follows the same logic for flu and COVID: vaccinate ahead of the expected wave, not during it.

In crowded indoor settings, on public transport, in hospitals and clinics, and whenever you have symptoms, wear a well-fitting respirator or quality surgical mask — it protects both you and others.

Open windows, prefer outdoor or airy seating, and keep some space in queues and waiting rooms — virus particles disperse outdoors and linger indoors.

Wash hands with soap for at least twenty seconds or use sanitizer after touching public surfaces, cover coughs and sneezes with your elbow, and stay home when ill — especially in the first symptomatic days, when contagiousness peaks. Knowing how long respiratory viruses stay contagious helps you judge when it is safe to return to work or family gatherings.

If you live with or visit elderly parents, people on cancer treatment, or anyone with diabetes, heart, kidney, or lung disease: test before visits, meet in ventilated rooms when cases are rising, and make sure they are boosted.

Travelers across Asia should check local trends before departure — the Bangkok Post recently reported roughly 15,000 new COVID cases per week in Thailand with NB.1.8.1 dominant. Carry rapid tests and masks, and have a testing plan if symptoms develop while traveling.

Key point: Vaccines plus ventilation plus masks in crowded places plus staying home when sick cuts your risk dramatically — and the same steps protect against flu, RSV, and other respiratory viruses.

How to Tell It Is COVID in 2026: Symptoms and Stages

NB.1.8.1 has one of the most distinctive symptom signatures of the Omicron era: an intense, burning sore throat described as feeling like swallowing razor blades. It often arrives as the very first symptom and is the worst part of the illness for many. NDTV’s health coverage notes that experts consider NB.1.8.1 highly contagious, consistent with its rapid spread across Asia.

Alongside the signature throat pain come pronounced fatigue that can outlast the other symptoms; a mild but persistent dry cough; low-to-moderate fever; muscle and body aches; nasal congestion; runny nose; and headache. Loss of taste or smell is now uncommon, though it still occurs. Roughly one in ten people develop gastrointestinal symptoms — nausea, loss of appetite, or diarrhea. RF.5 and PQ.16.1.1 appear to follow the same clinical pattern; no evidence suggests they cause more severe disease than other Omicron strains, and Thailand’s health officials describe these infections as generally mild.

A typical course: days 0–1, exposure with no symptoms; days 2–3, the sore throat begins, often severe, with fatigue and sometimes low fever; days 3–5, symptoms peak — congestion, cough, body aches, headache, possibly nausea — the most contagious window; days 5–7, fever breaks and throat pain eases, though cough and tiredness linger; days 7–10, most people recover, though a lingering dry cough and fatigue for another week or two is common.

Influenza, by contrast, tends to strike suddenly — high fever, chills, and abrupt, crushing exhaustion arriving within hours — whereas COVID-19 usually builds gradually, starting with the throat or congestion. For the deeper comparison, see our guide to the differences between flu A and flu B. Allergies bring itchy eyes, itchy nose, sneezing fits, and clear watery discharge — but never fever or body aches. The older XFG (“Stratus”) lineage, which still circulates, produces a cold-like pattern of congestion, cough, and prolonged tiredness nearly indistinguishable from COVID — which is exactly why testing matters.

Seek medical care promptly if you experience: difficulty breathing or shortness of breath; persistent chest pain or pressure; new confusion; inability to stay awake; or bluish lips or face. These are signs of severe illness and need emergency attention.

Which Tests Confirm COVID in 2026?

Because symptoms overlap so heavily between COVID, flu, and colds, testing is the only way to know for sure.

Rapid antigen tests — the lateral-flow home kits — remain the everyday first-line tool. They detect viral proteins in a nasal or throat swab and return a result in fifteen to thirty minutes. The sweet spot is days one through five of symptoms, when viral load is high enough to trigger the test. A positive result is reliable — treat it as COVID. A negative result in the first day or two is less trustworthy — antigen tests can miss early infections — so retest in 24–48 hours if symptoms persist.

RT-PCR is the laboratory gold standard. It detects the virus’s RNA itself, amplifying even tiny amounts of genetic material, making it far more sensitive than antigen tests. Doctors order PCR when symptoms are strong but the antigen test is negative, before procedures or hospital admissions, or for high-risk individuals; results take a few hours to a day. PCR can stay positive for weeks after recovery because it detects fragments of dead virus — a positive result two weeks after recovery does not mean you are still contagious.

Genomic sequencing is how scientists identify variants like NB.1.8.1, PQ.16.1.1, and RF.5. Selected positive samples go to specialized laboratories that read the virus’s full genome and match its mutation pattern to known lineages. This is surveillance, not routine clinical care — but it is why the UK Health Security Agency’s week-41 surveillance report can record RF.5 at 13.6% of sequenced cases in England in the week ending 8 October 2026.

Finally, pulse oximetry — the small fingertip device measuring blood oxygen saturation (SpO2) — is the most useful home monitoring tool for anyone with COVID. Normal readings are 95–100%; if yours falls to 94% or below, or you feel breathless, contact your doctor promptly. Checking once or twice daily is especially wise for the elderly and chronically ill.

Treatment and Emergency Medicines Guide

For most people, COVID-19 in 2026 needs no more than rest, fluids, and symptom relief — but for high-risk patients, modern antivirals can be life-saving if started early.

Antiviral drug classes are the centerpiece of treatment for high-risk patients: older adults, the immunocompromised, and people with chronic diseases. Nirmatrelvir-ritonavir is a protease inhibitor combination that blocks the viral enzyme which assembles new virus particles. Remdesivir is a polymerase inhibitor that disrupts the virus’s RNA-copying machinery; it is given by injection or infusion in healthcare settings. Molnupiravir is an oral drug that forces the virus to accumulate fatal copying errors. All share one critical rule: they must start within five days of symptom onset, while the virus is still actively replicating. Given late, they offer little benefit — so high-risk patients should test at the first symptom and contact their doctor immediately.

Supportive care — rest, fluids, and fever/pain relief — carries the majority of mild cases. Hospitalized patients with severe disease receive supplemental oxygen when blood oxygen falls, plus the corticosteroid dexamethasone, which calms the dangerous overactive immune response that damages the lungs. Dexamethasone is for hospitalized, oxygen-dependent patients only — not a home treatment for mild illness.

Treatment escalates in a clear sequence: antivirals within days for a high-risk patient with a positive test; oxygen therapy and monitoring if breathing worsens; dexamethasone and intensive respiratory support if lung inflammation progresses. The good news: the vast majority of 2026 infections never leave the first step.

Emergency Medicines Guide

The medicines below are drug classes commonly used for COVID symptoms, with generic names only. This tells you what category to ask about — never the dose. Dosage must always come from your doctor or pharmacist.

  • Fever and body aches → antipyretics/analgesics: acetaminophen (paracetamol) or ibuprofen.
  • Severe sore throat → throat relief: throat lozenges, topical anesthetic throat sprays, or warm salt-water gargles.
  • Dry, disruptive cough → cough suppressants: dextromethorphan; for chesty, mucus-producing cough, expectorants such as guaifenesin help loosen mucus.
  • Nasal congestion → decongestants: pseudoephedrine or oxymetazoline nasal spray (do not use nasal sprays for more than a few days); antihistamines such as loratadine or cetirizine may ease a runny nose.
  • Nausea → antiemetics: ondansetron, or ginger-based preparations for mild nausea.
  • Diarrhea and fluid loss → rehydration: oral rehydration salts.

Do not self-start prescription antivirals or antibiotics, do not combine multiple cold-and-flu products without checking overlapping ingredients, and do not exceed package NSAID guidance without consulting a doctor or pharmacist.

What to Eat During COVID

Eating well during COVID is about giving your immune system the raw materials it needs and replacing what illness takes away.

Fluids come first. Fever, mouth-breathing from congestion, sweating, and diarrhea all drain water, and dehydration thickens mucus and deepens fatigue. Drink water steadily through the day, add oral rehydration salts if you have diarrhea or heavy sweating, and use warm broths and clear soups — the warmth soothes the raw throat that NB.1.8.1 is known for. Herbal teas with honey and ginger help doubly: honey coats and calms the irritated throat, and ginger eases nausea.

Protein matters because immune cells are built from amino acids, and illness raises protein needs even as appetite drops. Aim for small, frequent, protein-rich meals rather than forcing three big ones. Soft options suit a sore throat best: eggs, lentils and dal, yogurt and kefir — which also support gut health when the virus or medicines disturb it — fish, and tender chicken.

Vitamin-C-rich produce — citrus, guava, bell peppers, tomatoes — supports immune-cell function, and zinc sources such as pumpkin seeds, chickpeas, lentils, and nuts support immune responses. If nausea kills your appetite, do not fight it: sip broths and rehydration drinks, eat tiny amounts often, and rebuild normal meals as the fever passes. Some weight loss during a week of illness is normal; poor eating beyond that deserves a doctor’s attention.

What to Avoid During COVID

Some foods and habits actively work against your recovery.

Alcohol comes first: it suppresses immunity, worsens dehydration, disrupts healing sleep, and can interact dangerously with prescription antivirals such as nirmatrelvir-ritonavir.

Smoking and vaping are the second non-negotiable. COVID already inflames the airways; adding tobacco or vape smoke further irritates the throat and lungs, deepens cough, and slows healing.

Very spicy foods, deep-fried snacks, and rough, crunchy foods aggravate a raw, inflamed throat — exactly the symptom NB.1.8.1 produces — so keep meals soft and mild until the throat pain resolves. Sugary soft drinks and excess sweets add no nutritional value and worsen dehydration.

Do not overuse painkillers: exceeding package directions or stacking multiple products containing acetaminophen risks liver injury. And a crucial correction — antibiotics do nothing against viruses. Taking them “just in case” cannot treat COVID, causes side effects, and fuels antibiotic resistance; they are only for bacterial complications a doctor diagnoses.

A Final Word of Encouragement

Catching COVID in 2026 is frustrating, but it is no longer the unknown it was in 2020. The virus is milder for most people, doctors have real treatments for those who need them, and vaccines keep the worst outcomes rare. Rest well, eat and drink with care, protect the vulnerable around you — and remember that every wave passes.

About the Reviewer

Dr. Ata Ullah — MBBS, MD Medicine, Physician Consultant. Dr. Ata Ullah is a Senior Medical Officer and Medical Specialist with extensive experience in internal medicine, infectious diseases, and adult and childhood immunization.

“Your Health, Our Responsibility.”

Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition.

Online Consultation: Dr. Ata Ullah (MBBS, MD Medicine), Physician Consultant / Medical Specialist — WhatsApp: 0315 7148181 — Consultation Fees: $30

1 thought on “New COVID Variants in 2026 (NB.1.8.1, PQ.16.1.1, RF.5): Symptoms, Spread, and How to Protect Yourself”

  1. Pingback: Mpox in 2026: Symptoms, How It Spreads, Testing & Treatment - CureWiser

Leave a Comment

Your email address will not be published. Required fields are marked *